ONCE hailed as a game-changer in the Covid-19 vaccine race, the AstraZeneca-Oxford vaccine has now found itself in a bind following incidents of a rare blood clot disorder among some recipients.
Malaysia is set to receive 600,000 doses of the vaccine in June.